Search results
Results from the WOW.Com Content Network
Beacon UK benchmarked IAPT performance across England for 2011–12 and reported that 533,550 people accessed (were referred to) IAPT services – 8.7% of people suffering from anxiety and depression disorders – with around 60% entering treatment sessions. Most local IAPT services did not reach the target of a 50% 'recovery' rate.
National Institute for Biological Standards and Control – responsible for the standardisation and control of biological medicines; The MHRA has several independent advisory committees which provide the UK Government with information and guidance on the regulation of medicines and medical devices.
The 2014 Adult Psychiatric Morbidity Survey found that 1 in 6 respondents had shown the symptoms of a common mental disorder in recent days, and 1 in 8 reported seeing mental health treatment. [8] [9] In the same year, the Health Survey for England found that 25% of respondents had been diagnosed with a mental illness at some point in their ...
These primary care trusts took over the functions of health authoriiesy, which were abolished under the National Health Service Reform and Health Care Professions Act 2002. [ 10 ] [ 11 ] Social care in England was reorganised to be structured into these trusts which would pool their services - this was the first time that health and social care ...
The Health and Social Care Act 2008 (Commencement No. 8) Order 2009 (S.I. 2009/270 (C.12)) The Health and Social Care Act 2008 (Commencement No. 9, Consequential Amendments and Transitory, Transitional and Saving Provisions) Order 2009 (S.I. 2009/462 (C.31))
In June 2022, the department published the Draft Mental Health Bill, stating the government's intention to modernise the existing Mental Health Act 1983. [ 9 ] In September 2022, the incoming Truss ministry divided the mental health and care portfolios and appointed Caroline Johnson to the former, with responsibility for mental health and ...
The Mental Health Act 2007 (c 12) is an Act of the Parliament of the United Kingdom. It amended the Mental Health Act 1983 and the Mental Capacity Act 2005. It applies to people residing in England and Wales. [3] Most of the Act was implemented on 3 November 2008. [4] It introduced significant changes which included:
In July 2023, the UK's primary pharmaceutical representative body, the Association of the British Pharmaceutical Industry (ABPI), responded to a publication of the indicators and assessed that inward life sciences foreign direct investment (FDI) had fallen by 47% in 2022 compared to 2021, falling to £1 billion from £1.9 billion.